Trazodone for the treatment of fibromyalgia: An open-label, 12-week study

BMC Musculoskeletal Disorders

Volumn 11, Issue , 2010, Pages

  Morillas Arques, Piedad ^a   Ma Rodriguez Lopez, Carmen ^a   Molina Barea, Rocio ^a   Rico Villademoros, Fernando ^a   Calandre, Elena P ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TRAZODONE; HYPNOTIC SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR;

ANXIETY; ARTICLE; DEPRESSION; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; FIBROMYALGIA; HEALTH SURVEY; HUMAN; MEASUREMENT; SCORING SYSTEM; SEDATION; SIDE EFFECT; SLEEP; TACHYCARDIA; XEROSTOMIA; ADULT; AGED; CLINICAL TRIAL; FEMALE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; SLEEP DISORDER;

ADULT; AGED; FEMALE; FIBROMYALGIA; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS; SLEEP DISORDERS; TRAZODONE; YOUNG ADULT;

EID: 77956492135     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-11-204     Document Type: Article

References (32)

1. Fibromyalgia syndrome module at OMERACT 9: domain construct. P Mease LM Arnold EH Choy DJ Clauw LJ Crofford JM Glass SA Martin J Morea L Simon CV trand DA Williams OMERACT Fibromyalgia Working Group, J Rheumatol 2009 36 2318 2329 10.3899/jrheum.090367 19820221
2. A review of the evidence for the efficacy and safety of trazodone in insomnia. WB Mendelson, J Clin Psychiatry 2005 46 469 476 10.4088/JCP.v66n0409
3. Treatment strategy in fibromyalgia syndrome: where are we now? P Sarzi-Puttini D Buskila M Carrabba A Doria F Artzeni, Semin Arthritis Rheum 2008 37 353 365 10.1016/j.semarthrit.2007.08.008 17976693
4. Guideline for the management of fibromyalgia syndrome pain in adults and children (complete summary). American Pain Society, National Guideline Clearinghouse http://www.guideline.gov accessed April 2010
5. Treatment of sleep abnormalities and clinical complaints in fibromyalgia with trazodone. JC Branco A Martini T Paiva, Arthritis Rheum 1996 39 91
6. Increased deep sleep after trazodone use: a double-blind placebo-controlled study in healthy young adults. JC Ware JT Pittard, J Clin Psychiatry 1990 51 Suppl 9 18 22 2211560
7. Effects of trazodone on polysomnography, blood concentration and core body temperature in healthy volunteers. H Yamadera H Suzuki S Nakamura S Endo, Psychiatry Clin Neurosci 1999 53 189 191 10.1046/j.1440-1819.1999.00531.x 10459685
8. Mechanism of action of trazodone: a multifunctional drug. SM Stahl, CNS Spectrums 2009 14 536 546 20095366
9. Therapeutic options in the treatment of insomnia. MK Erman, J Clin Psychiatry 2005 66 Suppl 9 18 23 16336038
10. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. F Wolfe HA Smythe MB Yunus RM Bennett C Bombardieri DL Goldenberg P Tugwell SM Campbell M Abeles P Clark SJ Farber CM Franklin RA Gatter D Hamaty J Lessard AS Lichtbroun AT Masi GA McCain WJ Reynolds TJ Romano IJ Russell RP Sheon, Arthritis Rheum 1990 33 160 172 10.1002/art.1780330203 2306288
11. Trazodone package insert. http://www.drugs.com/pro/trazodone.html accessed April 2010
12. Propiedades clinimétricas de la versián castellana del cuestionario de Pittsburgh. A Royuela JA Macías, Vigilia-Suẽo 1997 9 81 94
13. The Fibromyalgia Impact Questionnaire: A validated spanish version to assess the health status in women with fibromyalgia. J Rivera T Gonzlez, Clin Exp Rheumatol 2004 22 554 460 15485007
14. Fiabilidad y valores normales de la versián espãola del inventario para la depresián de Beck de 1978. C Vazquez J Sanz, Clin Salud 1997 8 403 422
15. Evaluation of the psychometric characteristics of the Spanish version of the Hospital Anxiety and Depression Scale. JM Quintana A Padierna C Esteban I Arostegui A Bilbao I Ruiz, Acta Psychiatr Scand 2003 107 216 221 10.1034/j.1600-0447.2003.00062.x 12580829
16. Validacián espãola del cuestionario Brief Pain Inventory en pacientes con dolor de causa neoplsica. X Badia C Muriel A Gracia JM Ñez-Olarte N Perulero R Galvez J Carulla CS Cleeland Grupo Vesbpi, Med Clin (Barc) 2003 120 52 10.1157/13042265 12570914
17. The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results. J Alonso L Prieto JM Antá Med Clin (Barc) 1995 104 771 776 7783470
18. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. MH Trivedi AJ Rush SR Wisniewski AA Nierenberg D Warden L Ritz G Norquist RH Howland D Lebowitz PJ McGrath K Shores-Wilson MM Biggs GK Balasubramani M Fava STAR*D Study Team, Am J Psychiatry 2006 163 28 40 10.1176/appi.ajp.163.1. 28 16390886
19. Polysomnographic effects of hypnotic drugs. A review. L Parrino MG Terzano, Psychopharmacology 1996 126 1 16 10.1007/BF02246405 8853211
20. Insomnia in somatoform pain disorder: sleep laboratory studies on differences to controls and acute effects of trazodone, evaluated by the Somnolyzer 24 × 7 and the Siesta database. B Saletu W Prause P Anderer M Mandl M Aigner O Mikova GM Saletu-Zyhlarz, Neuropsychobiology 2005 51 148 163 10.1159/000085207 15838186
21. Sleep cycles and alpha-delta sleep in fibromyalgia syndrome. J Branco A Atalaia T Paiva, J Rheumatol 1994 21 1113 1117 7932424
22. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. F Wolfe DJ Claw MA Fitzcharles DL Goldenberg RS Katz P Mease AS Russell IJ Russell JB Winfield MB Yunus, Arthritis Care Res 2010 62 600 610 10.1002/acr.20140
23. Combination therapy for fibromyalgia. AH Clayton SG West, Curr Pharm Design 2006 12 11 16 10.2174/138161206775193163
24. The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK. An observational study based on clinical practice. G Hughes C Martinez E Myon C Taeb S Wessely, Arthritis Rheum 2006 54 177 183 10.1002/art.21545 16385513
25. A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. F Wolfe J Anderson D Harkness RM Bennett XJ Caro DL Goldenberg IJ Russell MB Yunus, Arthritis Rheum 1997 40 1560 1570 10.1002/art.1780400904 9324009
26. Does the label "fibromyalgia" alter health status, function, and health service utilization? A prospective, within-group comparison in a community cohort of adults with chronic widespread pain. KP White WR Nielson M Harth T Ostbye M Speechley, Arthritis Rheum 2002 47 260 265 10.1002/art.10400 12115155
27. Aspirin and human sleep. JA Horne JE Percival JR Traynor, Electroencephalogr Clin Neurophysiol 1980 49 409 413 10.1016/0013-4694(80)90238- 2 6158420
28. The effects of two single doses of tramadol on sleep: a randomized, cross-over trial in healthy volunteers. B Walder MR Tramèr R Blois, Eur J Anaesthesiol 2001 18 36 42 11270008
29. Effects of ibuprofen on sleep quality as measured using polysomnography and subjective measures in healthy adults. F Gengo, Clin Ther 2006 28 1820 1826 10.1016/j.clinthera.2006.11.018 17213002
30. Comparative effects of duloxetine and desipramine on sleep EEG in healthy subjects. S Chalon A Pereira E Lainey F Vanderhende JG Watkin L Staner LA Granier, Psychopharmacology 2005 177 357 365 10.1007/s00213-004-1961-0 15290000
31. Trazodone: a review of its pharmacology, therapeutic use in depression, and therapeutic potential in other disorders. M Haria A Fitton D McTavish, Drugs Aging 1994 4 331 355 10.2165/00002512-199404040-00006 8019056
32. Complex adaptive systems allostasis in fibromyalgia. M Martinez-Lavin A Vargas, Rheum Clin Dis North Am 2009 35 285 298 10.1016/j.rdc.2009.05.005